Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
Yvon Lebranchu(Académie Nationale de Médecine), Gérard Rifle, Olivier Toupance(Centre Hospitalier Universitaire de Reims), Isabelle Étienne(Université Libre de Bruxelles), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), O Reigneau(Novartis (France)), Bruno Hurault de Ligny(Hôpital Georges-Clemenceau), P. Le Pogamp(Centre Hospitalier Universitaire de Rennes), Michel Guignard(Novartis (France)), Frank Bridoux(Université de Poitiers), Yannick Le Meur(Université de Bretagne Occidentale), Matthias Büchler(Centre Hospitalier Universitaire de Tours), Bruno Moulin(Université de Strasbourg)
Cited by 256
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809